Seattle Genetics Shares Outstanding 2006-2018 | SGEN

Seattle Genetics shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Seattle Genetics shares outstanding for the quarter ending September 30, 2018 were 0.159B, a 7.59% increase year-over-year.
  • Seattle Genetics 2017 shares outstanding were 0.143B, a 1.73% increase from 2016.
  • Seattle Genetics 2016 shares outstanding were 0.141B, a 8.95% increase from 2015.
  • Seattle Genetics 2015 shares outstanding were 0.129B, a 4.68% increase from 2014.
Seattle Genetics Annual Shares Outstanding
(Millions of Shares)
2017 143
2016 141
2015 129
2014 123
2013 122
2012 118
2011 113
2010 101
2009 91
2008 79
2007 61
2006 49
2005 42
Seattle Genetics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 159
Q2 2018 163
Q1 2018 152
Q4 2017 143
Q3 2017 148
Q2 2017 143
Q1 2017 142
Q4 2016 141
Q3 2016 141
Q2 2016 140
Q1 2016 140
Q4 2015 129
Q3 2015 128
Q2 2015 125
Q1 2015 124
Q4 2014 123
Q3 2014 124
Q2 2014 123
Q1 2014 123
Q4 2013 122
Q3 2013 122
Q2 2013 121
Q1 2013 120
Q4 2012 118
Q3 2012 118
Q2 2012 117
Q1 2012 116
Q4 2011 113
Q3 2011 115
Q2 2011 114
Q1 2011 109
Q4 2010 101
Q3 2010 101
Q2 2010 101
Q1 2010 103
Q4 2009 91
Q3 2009 93
Q2 2009 86
Q1 2009 84
Q4 2008 79
Q3 2008 80
Q2 2008 79
Q1 2008 76
Q4 2007 61
Q3 2007 66
Q2 2007 57
Q1 2007 55
Q4 2006 49
Q3 2006 51
Q2 2006 50
Q1 2006 42
Q4 2005 42
Q3 2005 42
Q2 2005 42
Q1 2005 42
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.197B $0.482B
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS? (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.735B 13.99
Gilead Sciences (GILD) United States $89.518B 10.78
Biogen (BIIB) United States $65.290B 13.22
Celgene (CELG) United States $48.703B 9.45
Illumina (ILMN) United States $47.030B 54.78
Vertex Pharmaceuticals (VRTX) United States $42.195B 73.71
Regeneron Pharmaceuticals (REGN) United States $37.368B 18.93
Alexion Pharmaceuticals (ALXN) United States $26.464B 18.11
BioMarin Pharmaceutical (BMRN) United States $17.041B 0.00
Incyte (INCY) United States $14.154B 391.23
Exact Sciences (EXAS) United States $8.773B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.028B 51.33
Sarepta Therapeutics (SRPT) United States $7.955B 0.00
QIAGEN (QGEN) Netherlands $7.897B 25.25
Alnylam Pharmaceuticals (ALNY) United States $7.391B 0.00
Bluebird Bio (BLUE) United States $6.855B 0.00
BeiGene (BGNE) Cayman Islands $6.829B 0.00
Bio-Techne Corp (TECH) United States $6.051B 40.88
Galapagos (GLPG) Belgium $5.361B 0.00
Alkermes (ALKS) Ireland $5.359B 3449.00
Exelixis (EXEL) United States $5.358B 15.19
Amarin (AMRN) Ireland $5.306B 0.00
Immunomedics (IMMU) United States $3.692B 0.00
Horizon Pharma Public (HZNP) Ireland $3.664B 15.08
Emergent Biosolutions (EBS) United States $3.631B 30.59
MorphoSys AG Unsponsored ADR (MOR) Germany $3.603B 0.00
Array BioPharma (ARRY) United States $3.490B 0.00
Ligand Pharmaceuticals (LGND) United States $3.283B 25.11
Allogene Therapeutics (ALLO) United States $3.224B 0.00
Guardant Health (GH) United States $3.113B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.046B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.999B 0.00
Repligen (RGEN) United States $2.871B 89.66
Genomic Health (GHDX) United States $2.753B 92.93
Ultragenyx Pharmaceutical (RARE) United States $2.694B 0.00
Akcea Therapeutics (AKCA) United States $2.675B 0.00
Ascendis Pharma (ASND) Denmark $2.497B 0.00
Allakos (ALLK) United States $2.484B 0.00
China Biologic Products (CBPO) China $2.467B 17.56
Blueprint Medicines (BPMC) United States $2.425B 0.00
Acceleron Pharma (XLRN) United States $2.413B 0.00
MyoKardia (MYOK) United States $2.384B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.368B 0.00
Myriad Genetics (MYGN) United States $2.348B 23.27
Halozyme Therapeutics (HALO) United States $2.332B 52.03
REGENXBIO (RGNX) United States $2.319B 31.11
Arena Pharmaceuticals (ARNA) United States $2.059B 0.00
Amicus Therapeutics (FOLD) United States $2.035B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.928B 0.00
Global Blood Therapeutics (GBT) United States $1.897B 0.00
AnaptysBio (ANAB) United States $1.835B 0.00
Denali Therapeutics (DNLI) United States $1.826B 0.00
Reata Pharmaceuticals (RETA) United States $1.779B 0.00
Aimmune Therapeutics (AIMT) United States $1.740B 0.00
Atara Biotherapeutics (ATRA) United States $1.702B 0.00
Innoviva (INVA) United States $1.651B 9.34
Rubius Therapeutics (RUBY) United States $1.599B 0.00
Cambrex (CBM) United States $1.587B 11.85
ORCHARD THERAPT (ORTX) United Kingdom $1.572B 0.00
G1 THERAPEUTICS (GTHX) United States $1.538B 0.00
NeoGenomics (NEO) United States $1.499B 123.92
Medicines (MDCO) United States $1.485B 0.00
Spark Therapeutics (ONCE) United States $1.479B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.408B 0.00
Editas Medicine (EDIT) United States $1.385B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.373B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.357B 0.00
Insmed (INSM) United States $1.331B 0.00
Mirati Therapeutics (MRTX) United States $1.331B 0.00
Myovant Sciences (MYOV) United Kingdom $1.329B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.253B 99.50
Solid Biosciences (SLDB) United States $1.199B 0.00
UniQure (QURE) Netherlands $1.187B 0.00
WAVE Life Sciences (WVE) Singapore $1.186B 0.00
Lion Biotechnologies (IOVA) United States $1.180B 0.00
Sangamo Therapeutics (SGMO) United States $1.144B 0.00
IMMURON LTD (IMRN) Australia $1.128B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.045B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.039B 0.00
Retrophin (RTRX) United States $1.038B 0.00
Audentes Therapeutics (BOLD) United States $1.004B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.988B 0.00
DBV Technologies (DBVT) France $0.951B 0.00
Acorda Therapeutics (ACOR) United States $0.941B 11.92
Lexicon Pharmaceuticals (LXRX) United States $0.924B 0.00
Cellectis (CLLS) France $0.915B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.907B 0.00
Puma Biotechnology (PBYI) United States $0.899B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.888B 0.00
Clovis Oncology (CLVS) United States $0.883B 0.00
Intra-Cellular Therapies (ITCI) United States $0.868B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.864B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.857B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.850B 0.00
Apellis Pharmaceuticals (APLS) United States $0.849B 0.00
Coherus BioSciences (CHRS) United States $0.835B 0.00
Viking Therapeutics (VKTX) United States $0.832B 0.00
Fate Therapeutics (FATE) United States $0.819B 0.00
Athenex (ATNX) United States $0.801B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.791B 0.00
Aptinyx (APTX) United States $0.784B 0.00
Revance Therapeutics (RVNC) United States $0.776B 0.00
Intellia Therapeutics (NTLA) United States $0.775B 0.00
Heska (HSKA) United States $0.770B 63.00
Dynavax Technologies (DVAX) United States $0.769B 0.00
Cara Therapeutics (CARA) United States $0.748B 0.00
TWIST BIOSCIENC (TWST) United States $0.748B 0.00
Vericel (VCEL) United States $0.736B 0.00
Novavax (NVAX) United States $0.697B 0.00
Gritstone Oncology (GRTS) United States $0.668B 0.00
InflaRx (IFRX) Germany $0.655B 0.00
CytomX Therapeutics (CTMX) United States $0.651B 0.00
UROGEN PHARMA (URGN) Israel $0.648B 0.00
AVROBIO (AVRO) United States $0.644B 0.00
AC Immune SA (ACIU) Switzerland $0.643B 0.00
ANI Pharmaceuticals (ANIP) United States $0.628B 12.00
Epizyme (EPZM) United States $0.627B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.621B 0.00
Senesco Technologies (ELOX) United States $0.611B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.608B 0.00
Principia Biopharma (PRNB) United States $0.606B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.568B 0.00
RA PHARMCTL INC (RARX) United States $0.541B 0.00
Arvinas (ARVN) United States $0.532B 0.00
UNITY Biotechnology (UBX) $0.520B 0.00
Eidos Therapeutics (EIDX) United States $0.519B 0.00
Arcus Biosciences (RCUS) United States $0.518B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.513B 0.00
Anika Therapeutics (ANIK) United States $0.507B 21.01
Scholar Rock Holding (SRRK) United States $0.506B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.498B 0.00
Kezar Life Sciences (KZR) United States $0.495B 0.00
Inovio Pharmaceuticals (INO) United States $0.488B 0.00
Mesoblast (MESO) Australia $0.480B 0.00
BeyondSpring (BYSI) United States $0.478B 0.00
Kura Oncology (KURA) United States $0.471B 0.00
ObsEva SA (OBSV) Switzerland $0.470B 0.00
Prothena (PRTA) Ireland $0.465B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.456B 0.00
Sorrento Therapeutics (SRNE) United States $0.454B 74.20
Replimune (REPL) United States $0.443B 0.00
PDL BioPharma (PDLI) United States $0.439B 7.17
Kindred Biosciences (KIN) United States $0.437B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.423B 0.00
Sinovac Biotech (SVA) China $0.421B 0.00
Five Prime Therapeutics (FPRX) United States $0.421B 0.00
MediciNova (MNOV) United States $0.413B 0.00
Zymeworks (ZYME) Canada $0.410B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.399B 0.00
Verastem (VSTM) United States $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.396B 0.00
Zealand Pharma (ZEAL) Denmark $0.376B 4.15
Cytokineticsorporated (CYTK) United States $0.369B 0.00
ResTORbio (TORC) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.362B 0.00
Osiris Therapeutics (OSIR) United States $0.357B 0.00
MeiraGTx Holdings (MGTX) United States $0.351B 0.00
Kodiak Sciences (KOD) United States $0.350B 0.00
Liquidia Technologies (LQDA) United States $0.345B 0.00
Seres Therapeutics (MCRB) United States $0.335B 0.00
Cellular Biomedicine (CBMG) United States $0.319B 0.00
Merus (MRUS) Netherlands $0.318B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
LogicBio Therapeutics (LOGC) United States $0.311B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.303B 0.00
Krystal Biotech (KRYS) United States $0.299B 0.00
Kadmon Holdings (KDMN) United States $0.296B 0.00
Geron (GERN) United States $0.296B 0.00
Equillium (EQ) United States $0.294B 0.00
MannKind (MNKD) United States $0.287B 0.00
Sutro Biopharma (STRO) United States $0.285B 0.00
Athersys (ATHX) United States $0.285B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.280B 0.00
Syros Pharmaceuticals (SYRS) United States $0.275B 0.00
BioDelivery Sciences (BDSI) United States $0.269B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.268B 0.00
Celyad SA (CYAD) Belgium $0.267B 0.00
Celcuity (CELC) United States $0.264B 0.00
Evelo Biosciences (EVLO) United States $0.263B 0.00
Arbutus Biopharma (ABUS) Canada $0.261B 0.00
Aduro Biotech (ADRO) United States $0.260B 0.00
Magenta Therapeutics (MGTA) United States $0.258B 0.00
Agenus (AGEN) United States $0.253B 0.00
TOCAGEN INC (TOCA) United States $0.247B 0.00
Axovant Sciences (AXON) United Kingdom $0.245B 0.00
Synlogic (SYBX) United States $0.243B 0.00
Unum Therapeutics (UMRX) United States $0.242B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.239B 0.00
Strongbridge Biopharma (SBBP) United States $0.238B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.237B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.237B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.233B 0.00
Urovant Sciences (UROV) United States $0.227B 0.00
Proteostasis Therapeutics (PTI) United States $0.225B 0.00
Kala Pharmaceuticals (KALA) United States $0.224B 0.00
Kamada (KMDA) Israel $0.214B 19.70
Xenon Pharmaceuticals (XENE) Canada $0.214B 0.00
Protagonist Therapeutics (PTGX) United States $0.212B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.210B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.204B 0.00
Idera Pharmaceuticals (IDRA) United States $0.203B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.199B 0.00
Intec Pharma (NTEC) Israel $0.195B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.193B 0.00
ChromaDex (CDXC) United States $0.192B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
NantKwest (NK) United States $0.181B 0.00
Allena Pharmaceuticals (ALNA) United States $0.179B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.176B 0.00
Compugen (CGEN) Israel $0.170B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.165B 0.00
Menlo Therapeutics (MNLO) United States $0.162B 0.00
PSivida (EYPT) United States $0.162B 0.00
Cerecor (CERC) United States $0.153B 0.00
XBiotech (XBIT) United States $0.148B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Mersana Therapeutics (MRSN) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
Spero Therapeutics (SPRO) United States $0.141B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.137B 0.00
Cohbar (CWBR) United States $0.134B 0.00
Selecta Biosciences (SELB) United States $0.134B 0.00
Eleven Biotherapeutics (SESN) United States $0.132B 0.00
Catalyst Biosciences (CBIO) United States $0.131B 0.00
Pluristem Therapeutics (PSTI) Israel $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Organovo Holdings (ONVO) United States $0.123B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.122B 0.00
XOMA (XOMA) United States $0.120B 0.00
Mustang Bio (MBIO) United States $0.116B 0.00
VBI Vaccines (VBIV) United States $0.115B 0.00
Motif Bio Plc (MTFB) United States $0.114B 0.00
OVID THERAPEUTC (OVID) United States $0.113B 0.00
Cue Biopharma (CUE) United States $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.111B 0.00
Anavex Life Sciences (AVXL) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Signal Genetics (MGEN) United States $0.107B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Chiasma (CHMA) United States $0.094B 0.00
Provention Bio (PRVB) United States $0.094B 0.00
Neothetics (EVFM) United States $0.091B 0.00
BioXcel Therapeutics (BTAI) United States $0.090B 0.00
Orgenesis (ORGS) United States $0.088B 0.00
Aptose Biosciences (APTO) Canada $0.087B 0.00
Cocrystal Pharma (COCP) United States $0.085B 94.77
Axsome Therapeutics (AXSM) United States $0.084B 0.00
Checkpoint Therapeutics (CKPT) United States $0.081B 0.00
Ophthotech (OPHT) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.079B 0.00
ScPharmaceuticals (SCPH) United States $0.076B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.075B 0.00
ITUS (ANIX) United States $0.075B 0.00
Monster Digital (INNT) United States $0.074B 0.00
Alcobra (ARCT) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.073B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Bionano Genomics (BNGO) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Evogene (EVGN) Israel $0.069B 0.00
Versartis (ARAV) United States $0.067B 5.89
Brainstorm Cell Therapeutics (BCLI) United States $0.065B 0.00
Aptevo Therapeutics (APVO) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.060B 0.00
Sophiris Bio (SPHS) United States $0.059B 0.00
Celldex Therapeutics (CLDX) United States $0.057B 0.00
Leap Therapeutics (LPTX) United States $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.056B 0.00
Bellerophon Therapeutics (BLPH) United States $0.056B 0.00
Trevena (TRVN) United States $0.053B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.053B 8.50
Oncobiologics (ONS) United States $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.052B 0.00
Curis (CRIS) United States $0.049B 0.00
OncoSec Medical (ONCS) United States $0.048B 0.00
AEterna Zentaris (AEZS) United States $0.048B 9.06
Caladrius Biosciences (CLBS) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
Oncolytics Biotech (ONCY) Canada $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.039B 0.00
TRACON Pharmaceuticals (TCON) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Galena Biopharma (SLS) United States $0.036B 0.00
GTx (GTXI) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
VIVUS (VVUS) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Therapix Biosciences (TRPX) Israel $0.030B 11.23
Histogenics (HSGX) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
OvaScience (OVAS) United States $0.024B 0.00
Cellect Biotechnology (APOP) Israel $0.023B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
Arsanis (ASNS) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00